Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 123.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 57,493
  • Market Cap: £128.87m
  • RiskGrade: 95

Deal with Barclays    Trade now with Barclays Stockbrokers

Cello Health buys US-based scientific consulting firm ISS

By Michele Maatouk

Date: Friday 16 Aug 2019

LONDON (ShareCast) - (Sharecast News) - Healthcare-led advisory group Cello Health has announced the acquisition of Innovative Science Solutions (ISS), a US-based scientific consulting firm, for up to $10.5m.
ISS specialises in strategic counsel and regulatory support for the healthcare industry. Since its foundation in 2000, it has helped many clients successfully navigate FDA advisory committee meetings, Cello said. The business also supports healthcare related clients with data provision in mounting legal defence around patent and intellectual property issues.

Cello will pay an initial consideration of $6.4m in cash, which will be funded from its existing cash and debt facilities. There will also be a deferred consideration of up to $4.1m payable in four tranches, each dependent on financial performance over the periods from 1 August 2019 to 31 July 2024.

For the year to 31 December 2018, ISS had an unaudited revenue of $5.0m, net revenue of $4.5m, unadjusted pre-tax profit of $2.8m and adjusted operating profit of $1.8 m. It's expected that post completion, ISS's operating profits will be lower than historical levels, reflecting the investment in senior headcount required "as the business rapidly develops the scale of its professional base to support its growing client franchise".

Cello Health chief executive Julia Ralston said: "We are excited about the acquisition of ISS at this stage in our US evolution. ISS has built a strong reputation for provision of its scientific consulting services. Adding this technical offer will benefit our clients, particularly by tackling their biggest challenges in navigating critical scientific, commercial, and regulatory pathways to successful commercialisation."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 123.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 139.50
52 Week Low 96.00
Volume 57,493
Shares Issued 104.77m
Market Cap £128.87m
RiskGrade 95

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.52% below the market average64.52% below the market average64.52% below the market average64.52% below the market average64.52% below the market average
65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average
Price Trend
0.95% below the market average0.95% below the market average0.95% below the market average0.95% below the market average0.95% below the market average
21.05% above the sector average21.05% above the sector average21.05% above the sector average21.05% above the sector average21.05% above the sector average
Income
16.02% above the market average16.02% above the market average16.02% above the market average16.02% above the market average16.02% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Growth
32.23% below the market average32.23% below the market average32.23% below the market average32.23% below the market average32.23% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 17-Sep-2019

Time Volume / Share Price
16:17 4,375 @ 124.50p
16:02 300 @ 124.50p
15:42 4,075 @ 124.50p
14:11 40 @ 122.10p
12:46 678 @ 124.76p

Cello Health Key Personnel

CEO Mark Scott

Top of Page